Uneek Mehra joined 4DMT as Chief Financial and Business Officer, Principal Financial Officer, Principal Accounting Officer and Assistant Secretary effective September 11, 2023. He resigned as Chief Financial and Business Officer effective July 15, 2025 to pursue other opportunities, agreeing to provide advisory services and remain as principal financial officer and principal accounting officer through September 2025. His departure was not the result of any disagreement with the Company.
Prior to joining 4DMT, Mr. Mehra served as Chief Financial and Business Officer and Principal Financial Officer of Myovant Sciences, Inc. from September 2021 to July 2023. From October 2019 to September 2021, he was Chief Financial Officer and Corporate Treasurer of PACT Pharma, Inc. He served as Chief Financial Officer at Proteus Digital Health, Inc. from April 2017 to October 2019, and from February 2004 until January 2017 served in various roles at Novartis AG, including as Global Head, Portfolio Management, Licensing and M&A, Oncology Business.
Mr. Mehra earned his Bachelors in Engineering from Birla Institute of Technology and Science, his Masters in Finance from Jamnalal Bajaj Institute of Management Studies, and his M.B.A. in Strategy and Leadership from the International Institute for Management Development.
Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.